SOBR Safe, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by SOBR Safe, Inc. on June 4, 2024, regarding a material definitive agreement entered into on the same date. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "SOBR".
Key Financial Metrics and Transaction Details
The filing details a warrant inducement transaction rather than standard operating financial results. Key metrics include:
- Warrant Conversion: The Holder converted 100% of the Applicable Warrants (10,319,163 warrants) at a reduced exercise price of $0.27 per share.
- New Warrant Issuance: In exchange, the Company issued 20,638,326 new warrants (New Warrants) to purchase an equal number of shares at an exercise price of $0.27.
- Transaction Fees: Aegis Capital Corp. served as the warrant inducement agent and financial advisor. The fee structure includes 8% of gross proceeds from the warrant exercise, 1% non-accountable expenses, and accountable expenses of $50,000.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions for the reporting period.
Material Changes
The primary material change is the reduction of the warrant exercise price to the Nasdaq Minimum Price ($0.27) to induce the conversion of existing warrants. This resulted in the immediate conversion of 10,319,163 warrants and the issuance of a larger volume of new warrants (20,638,326) to the Holder.
Guidance, Risks, and Unusual Items
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the transaction. The issuance of the New Warrants was conducted in reliance on the exemption from registration requirements under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, with the Holder representing it is an accredited investor.
Investor Verification Checklist
- Verify the total gross proceeds generated from the exercise of 10,319,163 warrants at $0.27 per share.
- Confirm the dilution impact of issuing 20,638,326 new warrants versus the 10,319,163 shares issued upon conversion.
- Review the effective status of the Form S-1 Registration Statement (File No. 333-267882) for the resale of Warrant Shares.
- Assess the total cost of the transaction including the 8% fee and $50,000 in accountable expenses paid to Aegis Capital Corp.